会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • BIOMONITORED SYNTHESIS ROUTE FOR LARGE SCALE PREPARATION OF CARDOL (BILOBOL) AND 11?-CARDOL
    • 生物化合物路线用于大规模制备CARDOL(BILOBOL)和11?
    • WO2005122670A3
    • 2007-07-05
    • PCT/BR2005000114
    • 2005-06-15
    • KARDOL IND QUIMICA LTDAPIRES DE LIMA DENISMARQUES MARIA RITAALVES SEVERINO ELIASMARQUES MUZZI ROZANNA
    • PIRES DE LIMA DENISMARQUES MARIA RITAALVES SEVERINO ELIASMARQUES MUZZI ROZANNA
    • C07C37/055C07C39/19
    • C07C51/09C07C37/055C07C41/18C07C41/20C07C41/22C07C41/26C07C41/30C07C45/56C07C49/84C07C51/377Y02P20/582C07C59/90C07C59/64C07C43/23C07C43/225C07C43/215C07C39/19
    • The present report is about a "biomonitored synthesis route for large scale preparation of cardol (bilobol) and 11 ?-cardol" in 15 steps. The 10 first steps are related to the production of Cardol, starting from 3,5-dimethoxy benzoic acid, and having the following intermediates 3,5-dimethoxybenzoyl chloride (1), 2-(3,5-Dimethoxy­benzoyl)-cyclohexanone (2), 7-(3,5- Dimethoxy-phenyl)-7-oxo-heptanoic acid (3), 7-(3,5-Dimethoxy-phenyl)-heptanoic acid (4), 7-(3,5- Dimethoxy­phenyl)-heptanoic acid ethyl ester (5), 7-(3,5-Dimethoxy-phenyl)-heptan-1-ol (6), 1-(7-lodo-heptyl )-3,5-dimethoxy-benzene (7), 1,3-Dimethoxy-5­pentadec-8-ynyl-benzene (8), 1 ,3-Dimethoxy-5-((Z)-pentadec-8-enyl )­benzene (9), up to the target product ((Z)-5-Pentadec-8-enyl)-benzene-1,3 diol or Cardol (10). In relation to the production of 11 ?-Cardol, it is started from the 1-(7-Iodo-heptyl)-3,5-dimethoxy-bénzene (7), by introducing specifically in this sequence the intermediates 10-(3,5-Dimethoxy-phenyl)-dec-2-yn-1-ol (11), 1 -(1 0-Iodo-dec-8-ynyl )-3,5-dimethoxy-benzene (12), 1,3-Dimethoxy-5­pentadeca-8,11-diynyl-benzene (13), 1,3-Dimethoxy-5-((8Z,I1Z)-pentadeca­8,11-dienyl)-benzene (14) and the target product ((8Z,11Z)-5-Pentadeca-8,11­dienyl)-benzene-1,3-diol (15) or 11 ?--cardol. All the intermediates and the target product had their obtaining methods generated in the concept of results optimization.
    • 本报告涉及15个步骤的“生物监测合成途径,用于大规模制备cardol(bilobol)和 11” - cardol“。 10个第一步涉及从3,5-二甲氧基苯甲酸开始制备Cardol,并具有以下中间体3,5-二甲氧基苯甲酰氯(1),2-(3,5-二甲氧基苯甲酰基) - 环己酮(2 ),7-(3,5-二甲氧基 - 苯基)-7-氧代 - 庚酸(3),7-(3,5-二甲氧基 - 苯基) - 庚酸(4),7-(3,5-二甲氧基苯基 ) - 庚酸乙酯(5),7-(3,5-二甲氧基 - 苯基) - 庚-1-醇(6),1-(7-羟基 - 庚基)-3,5-二甲氧基 - 苯(7 ),1,3-二甲氧基-5-十五碳-8-炔基 - 苯(8),1,3-二甲氧基-5 - ((Z) - 十八-8-烯基)苯(9),直到目标产物 (Z)-5-十五碳-8-烯基) - 苯-1,3-二醇或Cardol(10)。 关于生产“11” - 卡多尔,从1-(7-碘代庚基)-3,5-二甲氧基 - 乙腈(7)开始,特别是以该顺序引入 中间体10-(3,5-二甲氧基 - 苯基) - 癸-2-炔-1-醇(11),1-(10-十二碳-8-炔基)-3,5-二甲氧基 - 苯( 12),1,3-二甲氧基-5-十五碳-8,11-二炔基 - 苯(13),1,3-二甲氧基-5 - ((8Z,11Z) - 十八碳-8,11-二烯基) - 苯(14)和 目标产物((8Z,11Z)-5-十五碳-8,11-二烯基) - 苯-1,3-二醇(15)或11α-卡诺尔。 所有的中间体和目标产品都在结果优化的概念中产生了他们的获取方法。